These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10705872)

  • 21. Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors.
    Steffensen KD; Waldstrøm M; Andersen RF; Olsen DA; Jeppesen U; Knudsen HJ; Brandslund I; Jakobsen A
    Int J Oncol; 2008 Jul; 33(1):195-204. PubMed ID: 18575766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Overexpression of c-erbB-2 and p53 oncoprotein in renal pelvic and ureteral carcinomas with reference to the expression of Ki-67 antigen as a proliferation marker].
    Hashimoto H; Sue Y; Tokumitsu M; Saga Y; Yachiku S
    Nihon Hinyokika Gakkai Zasshi; 1997 Jun; 88(6):605-11. PubMed ID: 9234617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of C-erbB-2 (HER-2/neu) in patients with malignant and non-malignant diseases.
    Molina R; Jo J; Filella X; Bruix J; Castells A; Hague M; Ballesta AM
    Tumour Biol; 1997; 18(3):188-96. PubMed ID: 9143415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma.
    Sorak M; Arsenijević S; Lukić G; Arsenijević N; Ristić P; Pavlović S; Popović S; Baskić D
    J BUON; 2007; 12(1):99-104. PubMed ID: 17436409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas.
    van der Zee AG; Hollema H; Suurmeijer AJ; Krans M; Sluiter WJ; Willemse PH; Aalders JG; de Vries EG
    J Clin Oncol; 1995 Jan; 13(1):70-8. PubMed ID: 7799045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of c-erbB-2 and FGF-3 (INT-2) gene amplification in epithelial ovarian cancer.
    Seki A; Yoshinouchi M; Seki N; Kodama J; Miyagi Y; Kudo T
    Int J Oncol; 2000 Jul; 17(1):103-6. PubMed ID: 10853025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of c-erbB-2, c-myc, and c-ras oncoproteins, insulin-like growth factor receptor I, and epidermal growth factor receptor in ovarian carcinoma.
    van Dam PA; Vergote IB; Lowe DG; Watson JV; van Damme P; van der Auwera JC; Shepherd JH
    J Clin Pathol; 1994 Oct; 47(10):914-9. PubMed ID: 7962604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of c-erbB-2 in epithelial ovarian cancer. Prognostic value and relationship with response to chemotherapy.
    Felip E; Del Campo JM; Rubio D; Vidal MT; Colomer R; Bermejo B
    Cancer; 1995 Apr; 75(8):2147-52. PubMed ID: 7697606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of serum c-erbB-2 protein in breast cancer patients.
    Willsher PC; Beaver J; Pinder S; Bell JA; Ellis IO; Blamey RW; Robertson JF
    Breast Cancer Res Treat; 1996; 40(3):251-5. PubMed ID: 8883967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical relevance of soluble c-erbB-2 for patients with metastatic breast cancer predicting the response to second-line hormone or chemotherapy.
    Classen S; Kopp R; Possinger K; Weidenhagen R; Eiermann W; Wilmanns W
    Tumour Biol; 2002; 23(2):70-5. PubMed ID: 12065844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined measurement of the c-erbB-2 protein in breast carcinoma tissues and sera is useful as a sensitive tumor marker for monitoring tumor relapse.
    Sugano K; Ushiama M; Fukutomi T; Tsuda H; Kitoh T; Ohkura H
    Int J Cancer; 2000 Jul; 89(4):329-36. PubMed ID: 10956406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.
    Chen CH; Lin YS; Lin CC; Yang YH; Ho YP; Tsai CC
    J Oral Pathol Med; 2004 Nov; 33(10):589-94. PubMed ID: 15482324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.
    Nakamura T; Nekarda H; Hoelscher AH; Bollschweiler E; Harbeck N; Becker K; Siewert JR; Harbec N [corrected to Harbeck N]
    Cancer; 1994 Apr; 73(7):1785-94. PubMed ID: 7907940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The c-erbB transmembrane growth factor receptors as serum biomarkers in human cancer studies.
    Brandt-Rauf PW
    Mutat Res; 1995 Dec; 333(1-2):203-8. PubMed ID: 8538628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum levels of epidermal growth factor, transforming growth factor, and c-erbB2 in ovarian cancer.
    Balcan E; Demirkiran F; Aydin Y; Sanioglu C; Bese T; Arvas M; Akçay T; Cift T
    Int J Gynecol Cancer; 2012 Sep; 22(7):1138-42. PubMed ID: 22914212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. c-erbB-2 oncoprotein: a potential biomarker of advanced prostate cancer.
    Arai Y; Yoshiki T; Yoshida O
    Prostate; 1997 Feb; 30(3):195-201. PubMed ID: 9122045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum level and tissue expression of c-erbB-2 protein in lung adenocarcinoma.
    Osaki T; Mitsudomi T; Oyama T; Nakanishi R; Yasumoto K
    Chest; 1995 Jul; 108(1):157-62. PubMed ID: 7606952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of p105 (c-erbB-2, HER2/neu) serum levels by a new ELISA in patients with ovarian carcinoma.
    Marx D; Fattahi-Meibodi A; Kudelka R; Uebel T; Kuhn W; Meden H
    Anticancer Res; 1998; 18(4B):2891-4. PubMed ID: 9713482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective evaluation of tumor markers (c-erbB-2 oncoprotein, CEA and CA 15.3) in patients with locoregional breast cancer.
    Molina R; Filella X; Zanon G; Pahisa J; Alicarte J; Munoz M; Farrus B; Ballesta AM
    Anticancer Res; 2003; 23(2A):1043-50. PubMed ID: 12820345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenesis, p53, and c-erbB-2 immunoreactivity and clinicopathological features in male breast cancer.
    Shpitz B; Bomstein Y; Sternberg A; Klein E; Liverant S; Groisman G; Bernheim J
    J Surg Oncol; 2000 Dec; 75(4):252-7. PubMed ID: 11135266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.